Estrella Immunopharma, Inc. (ESLA)
1.58
-0.13
(-7.60%)
USD |
NASDAQ |
Apr 24, 16:00
1.60
+0.02
(+1.27%)
After-Hours: 20:00
Estrella Immunopharma EPS Diluted (Quarterly) : -0.0162 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.742 |
| Arcellx, Inc. | -1.003 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.6132M |
| Total Expenses (Quarterly) | 0.6132M |
| Enterprise Value | 66.03M |
| Earnings Yield | -22.60% |
| Normalized Earnings Yield | -22.59 |